Recombinant Human Desmoglein-4 Fc Chimera Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 9230-DM
Key Product Details
Source
HEK293
Accession #
Structure / Form
Disulfide-liked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Human embryonic kidney cell, HEK293-derived human Desmoglein-4 protein
Human Desmoglein-4 (Glu24-Ala631) Accession # Q86SJ6 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>80%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Glu24
Predicted Molecular Mass
94 kDa
SDS-PAGE
95-115 kDa, reducing conditions
Activity
Measured by the ability of the immobilized protein to support the adhesion of A431 human epithelial carcinoma cells.
The ED50 for this effect is 0.4-2.4 μg/mL.
The ED50 for this effect is 0.4-2.4 μg/mL.
Scientific Data Images for Recombinant Human Desmoglein-4 Fc Chimera Protein, CF
Recombinant Human Desmoglein-4 Fc Chimera Protein Bioactivity
Immobilized Recombinant Human Desmoglein‑4 Fc Chimera (Catalog # 9230-DM) supports the adhesion of A431 human epithelial carcinoma cells. The ED50 for this effect is 0.4-2.4 μg/mL.Formulation, Preparation and Storage
9230-DM
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 500 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Desmoglein-4
References
- Whittock, N.V. and C. Bower (2003) J. Invest. Dermatol. 120:523.
- Kljuic, A. et al. (2003) Cell 113:249.
- Bazzi, H. et al. (2006) Differentiation 74:129.
- Bazzi, H. et al. (2005) J. Investig. Dermatol. Symp. Proc. 10:222.
- Schaffer, J.V. et al. (2006) J. Invest. Dermatol. 126:1286.
- Shimomura, Y. et al. (2006) J. Invest. Dermatol. 126:1281.
- Zlotogorski, A. et al. (2006) J. Invest. Dermatol. 126:1292.
- Kato, M. et al. (2015) J. Invest. Dermatol. 135:1253.
- Nagasaka, T. et al. (2004) J. Clin. Invest. 114:1484.
- Calkins, C.C. et al. (2006) J. Biol. Chem. 281:7623.
Alternate Names
Cad13, CDGF13, CDHF13, Desmoglein4, DSG4
Gene Symbol
DSG4
UniProt
Additional Desmoglein-4 Products
Product Documents for Recombinant Human Desmoglein-4 Fc Chimera Protein, CF
Product Specific Notices for Recombinant Human Desmoglein-4 Fc Chimera Protein, CF
For research use only
Loading...
Loading...
Loading...